← Back to All Filings

Insmed Officer Files Intent to Sell $5.8M in Stock (INSM)

Low SignificanceNovember 12, 2025 at 5:03:47 PM EST

INSMED Inc

$INSM144CIK: 0001104506

Subscribe to track INSM

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Insmed Officer Files Intent to Sell $5.8M in Stock (INSM)

Company: INSMED Inc (INSM) Form: 144 | Filed: 2025-11-12 Significance: Low

Insider: Stacey Nicole Schaeffer Orlov Title: Officer | Relationship: Officer

Transaction: • Type: Proposed Sale • Shares: 30,000 • Value: $5,835,300 • Price/Share: ~$194.51

Key Insight: An officer has filed a notice of proposed sale. The transaction size is very small relative to the company's $40.9B market cap, representing only 0.014% of market value and 0.014% of shares outstanding.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: INSMED Inc (INSM)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An officer at Insmed has filed a notice of intent to sell 30,000 shares of common stock, valued at approximately $5.8 million.
  • Market Impact: The proposed sale is of low materiality, representing a negligible fraction of the company's market capitalization and outstanding shares, suggesting a minimal market impact.

Company Information

FieldValue
CompanyINSMED Inc
Ticker SymbolINSM
CIK0001104506
IndustryPharmaceutical Preparations

Insider Information

FieldValue
NameStacey Nicole Schaeffer Orlov
CIK0001401017
Title/PositionOfficer
RelationshipOfficer

Transaction Details

FieldValue
Form Type144
Transaction Date2025-11-12 (Approximate Sale Date)
Transaction CodeNot Applicable (Proposed Sale)
Security TypeCommon Stock
Shares Involved30,000
Price Per Share~$194.51 (Calculated)
Total Value$5,835,300
Shares Owned AfterNot Disclosed
Ownership TypeNot Disclosed

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$5,835,300
% of Market Cap0.014%
Shares Transacted30,000
% of Shares Outstanding0.014%
Post-Transaction OwnershipNot Disclosed
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a large-cap company with a market capitalization of $40.93 billion, this $5.8 million transaction is considered routine and financially immaterial.
  • Transaction Significance: The sale represents a very small fraction of both market value (0.014%) and shares outstanding (0.014%), falling well below the thresholds for moderate or high significance. Such sales are common for executive liquidity, tax planning, or portfolio diversification and do not typically signal a change in the insider's outlook on the company.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction's size is insignificant relative to the company's large market capitalization and daily trading volume. It is unlikely to have any discernible impact on the stock price.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The 30,000 shares can be easily absorbed by the market without affecting liquidity.
  • Sentiment Indicator: Neutral. The filing is a procedural notice of a minor sale and does not provide a strong bullish or bearish signal.

Additional Context

Transaction Notes

  • Recent Activity: The filing notes two other sales by the same insider in the preceding three months: 76,520 shares on 09/12/2025 and 10,000 shares on 08/14/2025. While this indicates a pattern of selling, the cumulative amount remains immaterial relative to the company's size.
Topics:#SECFiling#InsiderTrading#INSM#Insmed#Form144#InsiderSell#StockMarket#Biotech#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.